Trials / Recruiting
RecruitingNCT07451613
Safety and Tolerability Study of Human Neural Stem Cells for Huntington's Disease
Phase 1B/2A Study of the Safety and Tolerability of Human Neural Stem Cells for Huntington's Disease
- Status
- Recruiting
- Phase
- Phase 1 / Phase 2
- Study type
- Interventional
- Enrollment
- 21 (estimated)
- Sponsor
- Leslie Thompson · Academic / Other
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this research study is to determine whether an implantation of hNSC-01 is a safe and tolerable study intervention for Huntington's disease. This study is the first time that hNSC-01 is being tested in people.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BIOLOGICAL | hNSC-01 | neural stem cell therapy |
Timeline
- Start date
- 2026-04-06
- Primary completion
- 2028-06-01
- Completion
- 2031-01-01
- First posted
- 2026-03-05
- Last updated
- 2026-04-13
Locations
1 site across 1 country: United States
Regulatory
- FDA-regulated drug study
Source: ClinicalTrials.gov record NCT07451613. Inclusion in this directory is not an endorsement.